Breath test spots kidney risk: Trace Sensing Technologies

Breath analysis: Trace Sensing Technologies’ flagship platform, TRACE-E, uses patented thermodynamic sensor technology to detect molecular biomarkers in exhaled breath, improving disease detection. Peter Ricci III, founder and CEO, works on the machine. 
PBN PHOTO/TRACY JENKINS
Breath analysis: Trace Sensing Technologies’ flagship platform, TRACE-E, uses patented thermodynamic sensor technology to detect molecular biomarkers in exhaled breath, improving disease detection. Peter Ricci III, founder and CEO, works on the machine. 
PBN PHOTO/TRACY JENKINS

Innovative Companies 2026 Awards BIOTECH/LIFE SCIENCES: Trace Sensing Technologies Trace Sensing Technologies, a Providence-based medical technology company, has developed a diagnostic tool that could make detecting serious disease as simple as breathing out. The 6-year-old company’s flagship platform, TRACE-E, uses patented thermodynamic sensor technology to detect molecular biomarkers in exhaled breath, replacing needles and lab

Already a Subscriber? Log in

To Continue Reading This Article

Become a Providence Business News subscriber and get immediate access to all of our premier content and much more.

Learn More and Become a Subscriber

No posts to display